Vote!
[Comment] Targeting of intermittent preventive treatment for malaria
Common sense dictates that African children surviving hospital admittance for severe malaria and anaemia likely remain at high risk of malaria reinfection and should be followed up closely in the months after discharge. In The Lancet Infectious Diseases, Kamija Phiri and colleagues report a randomised placebo-controlled trial showing that, for such children admitted to hospital and requiring blood transfusion, initial (during hospital stay) and then repeated treatment with artemether–lumefantrine at 1 month and 2 months after discharge provides substantial short-term benefit by lowering the likelihood of death, hospital admittance, and...
Published By: MedWorm/DeathRecovery - Wednesday, 22 February
- Older News
- Vote! Prevention vs. Treatment: What's the Right Balance?
MedWorm/RelationshipIssues (Yesterday) - Two very different books by leaders in the field of preventive medicine have been recently...
